From the investor call today, it appears that that rate of cash burn will continue until FDA submission in around 4-8 weeks, then they will scale down costs pending a number of outcomes (revenues, FDA approval, wider regulatory approvals etc).
They're walking a tight line.
I think its pretty clear still that everything turns on FDA. Hopefully approved by July-August.
If FDA obtained I think I'd be fairly relaxed about them raising/sourcing capital and continuing to spend. If no FDA approval its probably fu*t.
From the investor call today, it appears that that rate of cash...
Add AYA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.5¢ |
Change
0.005(1.61%) |
Mkt cap ! $24.79M | |||
| Open | High | Low | Value | Volume |
| 30.5¢ | 32.0¢ | 28.0¢ | $40.57K | 134.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1854 | 27.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.5¢ | 18777 | 1 |
View Market Depth
| Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
| AYA (ASX) Chart |